Bad Blood: Secrets and Lies in a Silicon Valley Startup
- This purchase will help support literacy campaigns across the world
- BUY ONE GIVE ONE
A New York Times Bestseller
Longlisted for the Financial Times and McKinsey Business Book of the Year Award
'Chilling . . . Reads like a West Coast version of All the President's Men.' New York Times Book Review
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Now to be adapted into a film, with Jennifer Lawrence to star.
|Number Of Pages||320|
|Item Height||26 mm|
|Item Width||131 mm|
|Item Weight||350 Gram|
|Product Dimensions||131 x 26 x 198|
|Format||Paperback | 320|
A dazzling story of deception in Silicon Valley . . . It is a tale of heroic cupidity on a scale that made the very best and the very brightest look like the very, very foolish . . . You will not be able to put this book down. * Washington Post *
Riveting . . . a blistering critique of Silicon Valley, a kind of nonfiction corollary to Dave Eggers's The Circle . . . compelling . . . [Carreyrou's] unmasking of Theranos is a tale of David and Goliath . . . The real heroes, though, are his sources: the young scientists who worked at the company and risked their reputations and careers by voicing their concerns. Were it not for their courage, Theranos might still be testing blood today -- David Crow * Financial Times *
Carreyrou tells the story virtually to perfection . . . Bad Blood reads like a West Coast version of All the President's Men. * New York Times *
Gripping . . . Carreyrou presents the scientific, human, legal and social sides of the story in full . . . He unveils many dark secrets of Theranos that have not previously been laid bare. * Nature *
Gripping . . . It is a parable, with all the usual, delicious ingredients of human folly: greed, pride, vanity, lust, anger. Above all, it is an analysis of the phenomenon of hype. * Daily Telegraph *
Simply one of the best books about a startup ever. * Forbes *
Bad Blood reveals a crucial truth: outside observers must act as the eyes, the ears and, most importantly, the voice of Silicon Valley's blind spot . . . It gambled not with our smart phones, our attention or our democracy, but with people's lives. * Paste *
Engaging * The Economist *